Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Recovery article

Coremend Blend (BPC-157, KPV, TB-500) Dosage Guide, Benefits & Side Effects

Coremend Blend (BPC-157, KPV, TB-500) Dosage Guide, Benefits & Side Effects This high-dose three-peptide blend combines TB-500, BPC-157, and KPV in one injection; research on the combination itself remains limited. Chemical Makeup 13 Amino Acids Coremend Blend

Coremend Blend (BPC-157, KPV, TB-500) Dosage Guide, Benefits & Side Effects

This high-dose three-peptide blend combines TB-500, BPC-157, and KPV in one injection; research on the combination itself remains limited.

Chemical Makeup

13

Amino Acids

Coremend Blend (BPC-157, KPV, TB-500)

Thr

Position 1

Asx

Position 2

Position 3

Pro

Position 4

Cys

Position 5

Lys

Position 6

Position 7

Val

Position 8

Arg

Position 9

Ala

Position 10

Position 11

Ile

Position 12

Pyl

Position 13

As seen on

Coremend Blend (BPC-157, KPV, TB-500) Dosage Guide for Recovery & RepairCoremend Blend (BPC-157, KPV, TB-500) Dosage Calculator

This blend combines BPC-157, KPV, and TB-500 to support gut healing and tissue repair throughout the body.

Vial size

10 mg

Bacteriostatic water

2 mL

Dosing

250–500 mcg

Frequency

Daily

Cycle

4–8 weeks

Benefit

Recovery & Repair

What is Coremend Blend (BPC-157, KPV, TB-500)?

Coremend is a healing-focused peptide blend combining a higher dose of TB-500 with BPC-157 and KPV, designed for more intensive tissue repair needs than a standard blend. TB-500 supports cell movement and repair, BPC-157 boosts growth-factor signaling for healing, and KPV calms inflammation. Its higher ratio of TB-500 is aimed at more significant injuries or faster recovery needs.

Healing

Research targets include tissue repair, wound healing, and recovery from injury.

core

Is Coremend Blend (BPC-157, KPV, TB-500) FDA approved?

Coremend Blend (BPC-157, KPV, TB-500) is not an FDA-approved drug. It is intended for research purposes only and is not approved for human consumption, diagnostic, or therapeutic use.

Research Use Only

Coremend Blend (BPC-157, KPV, TB-500) has not been evaluated by the FDA for safety or efficacy in humans.

No Clinical Oversight

Not manufactured under FDA-regulated quality or clinical standards.

Unregulated Sourcing

Purity, dosing, and sourcing are not verified through FDA testing or oversight.

Our top-rated vendor

View all vendors

Our rankings are based solely on third-party lab testing rigor, COA transparency, and pricing — no paid placements, no affiliate influence. We update this list as new data comes in.

Based on current scores, this vendor ranks highest across those criteria.

Protide Health

#1 Rated Research Peptide Supplier

How Does Coremend Blend (BPC-157, KPV, TB-500) Work?

One peptide in this blend helps cells migrate to the injury and supports new blood vessel formation, another boosts growth factors that speed wound healing and protect the gut, and the third calms inflammatory signaling and may make injections more comfortable. Together, they target inflammation, tissue regrowth, and cellular repair from different angles.

Migration & vessel growth

One peptide helps cells migrate to the injury and supports new blood vessels.

Growth factors & protection

Another boosts growth factors that speed healing and protect the gut.

Calms inflammation

The third calms inflammatory signaling at the injury site.

Coremend Blend (BPC-157, KPV, TB-500) Targeted areas

How to reconstitute Coremend Blend (BPC-157, KPV, TB-500)

The materials you'll need and step-by-step instructions for safely mixing Coremend Blend (BPC-157, KPV, TB-500) with bacteriostatic water.

Materials needed

Your Coremend Blend (BPC-157, KPV, TB-500) vial (lyophilized)

Alcohol swabs

Bacteriostatic sterile water

3 mL syringes (Luer Lock tip)

25G or 27G needles (Luer Lock). Other gauges may also be acceptable.

Sharps container (optional)

Remove the caps

Sanitize the rubber stoppers

Attach the needle

Draw the bac water

Pull back on the plunger to draw your desired volume of bacteriostatic water. If you overfill, just push the excess back in until you reach the right marker on the syringe.

Insert the needle into the Coremend Blend (BPC-157, KPV, TB-500) vial

With the bac water in your syringe, insert the needle into the Coremend Blend (BPC-157, KPV, TB-500) vial at a slight angle to avoid pressure buildup.

Release the water gently

Let the water run gently down the side of the vial. Don't inject it forcefully.

Swirl to dissolve

Avoid shaking. Gently swirl, flip, and roll the vial to dissolve the powder.

Check for full dissolution

Cap, dispose, and store

How to Store Coremend Blend (BPC-157, KPV, TB-500)

Once mixed with liquid, keep it in the fridge and use it within 4–6 weeks.

Reconstituted Storage

2–8°C.

Usage Window

Use within 4–6 weeks.

What Are the Benefits of Coremend Blend (BPC-157, KPV, TB-500)?

What research says it may help with, and how it works in the body.

tissue healing

A higher dose of TB-500 is used for more serious tissue damage that needs stronger repair support.

The blend supports collagen, the protein that gives tissue its structure, while also boosting the body's natural growth signals for repair.

TB-500 helps repair damaged muscle fibers and helps the right cells travel to the injury site to aid healing.

postsurgical recovery

It supports recovery from surgical wounds through several different mechanisms working together.

The KPV part of the blend helps calm down inflammation that follows surgery.

By improving how tissue rebuilds itself, it may help reduce the amount of scarring.

sports medicine

It helps people get back to physical activity faster after a sports injury.

It helps address the buildup of tissue damage caused by repetitive strain over time.

What Are the Side Effects of Coremend Blend (BPC-157, KPV, TB-500)?

Who should avoid it, warning signs to watch for, and what to know before combining it with other compounds.

Who Should Avoid It

No clinical trials on this three-peptide combination

Active cancer (theoretical concern with growth-promoting peptides)

Pregnancy or breastfeeding

Active infection at injection site

Stop Right Away If You Notice

Severe injection site reactions or signs of infection

Allergic reactions (rash, swelling, difficulty breathing)

Unusual bleeding or bruising

Worsening of underlying conditions

Milder Signs to Watch For

Coremend Blend (BPC-157, KPV, TB-500) contains these peptides

The individual peptides blended together to make Coremend Blend (BPC-157, KPV, TB-500).

bpc

Longevity

BPC-157

Preclinical

kpv

Immunity

KPV

tb5

TB-500

How Long Should a Coremend Blend (BPC-157, KPV, TB-500) Cycle Last?

This breaks down how long a typical Coremend Blend (BPC-157, KPV, TB-500) cycle runs and what research suggests happens at each stage. Research shows that staying on a peptide continuously, without a break, may make it less effective over time.

That's why most research protocols build in a break between cycles, often called a washout period, to let the body reset before starting again.

Related peptides

fox

FOXO4-DRI

Growth

ghr

GHRP-2

Approved

ghrp

GHRP-6

Phase 1

glu

Glutathione

Phase 2

Cheat Sheets Featuring Coremend Blend (BPC-157, KPV, TB-500)

See how Coremend Blend (BPC-157, KPV, TB-500) fits into a broader research stack with these free downloadable cheat sheets. Each one includes reference dose ranges, dosing frequency, and half-life for every peptide it covers. For research purposes only.

18 peptides

42 peptides

78 peptides

Browse user-created protocols

Real protocols from the community that include Coremend Blend (BPC-157, KPV, TB-500)

Daily peps

Kennedy

Weight

GLP-3

Skin

MT-1

Coremend Blend (BPC-157, KPV, TB-500) Research References

It is a limited research compound

Coremend Blend (BPC-157, KPV, TB-500) is a limited research compound

TB-500 promotes cell migration, blood vessel formation, and wound healing through actin modulation.

n.d.

BPC-157 upregulates growth factors and accelerates healing of various tissue types.

KPV (alpha-MSH 11-13) inhibits NF-κB pathway and reduces pro-inflammatory cytokines.

Frequently Asked Questions About Coremend Blend (BPC-157, KPV, TB-500)

Straight answers on reconstitution, dosing, and safety, everything you need to research with confidence. For research reference only.

What is Coremend and what does it contain?

Coremend is a research peptide blend that combines three peptides in a single vial: BPC-157, TB-500, and KPV. Formulations vary by supplier, but a common ratio is TB-500 25 mg, BPC-157 10 mg, and KPV 10 mg per vial (about 45 mg total), though some vendors sell an equal 10 mg/10 mg/10 mg version. It is marketed for researchers studying tissue repair, wound healing, and inflammation, and is sold strictly for laboratory/research use, not for human or veterinary use.

Why are BPC-157, TB-500, and KPV combined together?

Each peptide is proposed to act on a different phase of the tissue-repair process. KPV (a fragment of alpha-MSH) is studied for anti-inflammatory activity, reportedly by inhibiting the NF-κB signaling pathway and reducing pro-inflammatory cytokines. BPC-157 is studied for its effects on growth factor upregulation and blood vessel formation (angiogenesis). TB-500 (a synthetic fragment of thymosin beta-4) is studied for promoting cell migration and actin regulation involved in structural tissue remodeling. The rationale for combining them is 'triple-mechanism' coverage of inflammation control, vascular repair, and structural rebuilding, though the combined blend itself has not been evaluated in clinical trials.

How is Coremend reconstituted and stored?

Vials are typically lyophilized (freeze-dried powder) and reconstituted with bacteriostatic water — commonly around 2–3 mL per vial, which for a 45 mg vial yields approximate concentrations of roughly 8.3 mg/mL TB-500, 3.3 mg/mL BPC-157, and 3.3 mg/mL KPV (concentrations scale differently for a 10/10/10 mg vial). Unopened lyophilized vials are generally stored refrigerated or frozen (around -20°C to 6°C), protected from light and heat, and are reported stable for up to about 24 months. After reconstitution, the solution should be kept refrigerated at 2–8°C and most vendors recommend using it within roughly 30 days; reconstituted peptides should never be frozen, as ice crystal formation can damage the peptide structure.

What dosages and injection schedules are typically discussed for this stack?

Dosing information for this blend comes from research/vendor guides rather than clinical studies, and protocols vary. Commonly cited reference ranges for the individual components are BPC-157 at roughly 250–500 mcg once or twice daily, KPV at roughly 200–500 mcg daily, and TB-500 at roughly 2–2.5 mg twice weekly during an initial loading phase, then once weekly for maintenance. Administration discussed in these sources is typically subcutaneous injection, sometimes near an injury site. Actual dosing for a specific Coremend vial depends on its stated concentration and should be calculated from the vial's labeled mg content and reconstitution volume.

How long are cycles typically run, and is a break needed?

Guides discussing this stack commonly describe cycles of about 6–8 weeks, sometimes extended to 12 weeks for more chronic conditions, followed by a 2–4 week break before considering another cycle. The rationale given is to allow assessment of whether healing is holding without peptide support and to let the body's own signaling systems return to baseline. These are conventions found in vendor and enthusiast literature, not established clinical protocols.

What side effects are reported with this peptide blend?

Reported effects in user and vendor sources include injection-site redness, soreness, or minor swelling; mild skin flushing (particularly associated with KPV or melanocortin-pathway peptides); nausea (more often reported with oral BPC-157 use); transient fatigue; headache; and occasional dizziness. These reports come from anecdotal and vendor sources rather than controlled human trials, so the true frequency and severity of side effects in humans are not well established. Because the blend is not approved for human use, no verified human safety profile exists.

Is Coremend approved or legal to use?

BPC-157, TB-500, and KPV are not approved by the FDA (or equivalent regulators) for human or veterinary use, and this specific three-peptide combination has not been studied in clinical trials. Products described as 'Coremend' are sold by research chemical vendors explicitly for laboratory and in-vitro research purposes only, not for human consumption. Regulatory status varies by country and has been tightening in some jurisdictions (e.g., restrictions on compounding pharmacies selling BPC-157). Competitive athletes should also note that peptides in this category are commonly restricted under anti-doping (WADA) rules. Anyone considering this product should check current local laws and consult a licensed medical professional rather than relying on vendor marketing.

How is Coremend tested for purity and identity?

Reputable vendors report third-party laboratory testing using methods such as HPLC-UV for purity and LC-MS for identity confirmation, with Certificates of Analysis (COAs) made available per batch. Because this is an unregulated research-chemical market, purity and accuracy of labeling can vary significantly between suppliers, so checking for an independent, batch-specific COA is commonly recommended before use in any research setting.

CONNECTED / MODULES

Post-session references

Selected from shared article topics. Source links are retained where available.

01

Handling & safety lane

Source-derived education, not individual medical guidance or an instruction to dose.

DOSAGE SOURCE

Dosage Protocols

No standardized dosing protocols have been established through clinical trials for human use. The following protocols are derived from anecdotal reports and extrapolation from research settings. Loading Phase: Conservative protocols recommend 1.0–1.5 mg administered subcutaneously or intramuscularly twice weekly (2–3 mg weekly total) for 4–6 weeks. Some community protocols use higher doses, but no human clinical trial data exists to support specific loading doses. Maintenance Phase: Following the loading period, dosing typically reduces to 1–2 mg once weekly to maintain therapeutic effects. Cycling Considerations: Typical active use: 4–6 weeks Common protocol: 4–6 weeks on, 2–4 weeks off before resuming if needed Chronic conditions may require extended or adjusted protocols
03

Evidence cooldown

Research context and source excerpts for a slower second read.

RESEARCH

The Future of Peptide Research in 2026

Looking ahead to 2026, the potential for peptides like TB-500 continues to expand exponentially. Advances in understanding cellular signaling pathways and regenerative medicine are constantly opening new avenues for exploration. A robust and well-understood TB-500 dosage guide will remain a cornerstone for unlocking these future discoveries. We anticipate even more nuanced protocols emerging as researchers delve deeper into specific applications, requiring even greater precision. Our team is constantly monitoring these developments, ensuring that our product offerings, from SLU-PP-332 Capsules (sloop) to FOXO4-DRI, remain at the forefront of scientific demand. We're committed to supporting the research community with the tools they need to push boundaries. We invite you to explore our full range of high-purity research peptides and find the right peptide tools for your lab, knowing you're partnering with a company that values precision as much as you do. Discover premium peptides for research that truly make a difference, backed by a thorough understanding of their potential, which always starts with the right TB-500 dosage guide. For any researcher embarking on studies involving compounds like TB-500 (thymosin Beta-4), a deep understanding of dosage principles isn't just beneficial; it's foundational. It's about ensuring every experiment is conducted with the utmost rigor, leading to discoveries that can truly reshape our understanding of biological processes. Your commitment to precision is mirrored in our dedication to quality, making every research journey a shared endeavor towards scientific excellence.